Page last updated: 2024-10-26

etodolac and Lipid Metabolism Disorders

etodolac has been researched along with Lipid Metabolism Disorders in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Lipid Metabolism Disorders: Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.

Research Excerpts

ExcerptRelevanceReference
"Etodolac is a nonsteroidal anti-inflammatory drug which has been demonstrated to protect liver against fibrosis."1.40Impact of N-acetylcysteine and etodolac treatment on systolic and diastolic function in a rat model of myocardial steatosis induced by high-fat-diet. ( Akkoc, H; Akkus, M; Kelle, I; Topal, AE; Topal, D; Yilmaz, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topal, AE1
Akkoc, H1
Kelle, I1
Yilmaz, S1
Topal, D1
Akkus, M1

Other Studies

1 other study available for etodolac and Lipid Metabolism Disorders

ArticleYear
Impact of N-acetylcysteine and etodolac treatment on systolic and diastolic function in a rat model of myocardial steatosis induced by high-fat-diet.
    Endocrine, metabolic & immune disorders drug targets, 2014, Volume: 14, Issue:4

    Topics: Acetylcysteine; Animals; Cardiomyopathies; Diastole; Diet, High-Fat; Disease Models, Animal; Etodola

2014